Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003-2011

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Armstrong, April W ^a   Schupp, Clayton ^a   Wu, Julie ^a   Bebo, Bruce ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Psoriasis Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANGER; ARTICLE; E-MAIL; EMPLOYMENT STATUS; FEMALE; FRUSTRATION; GENDER; HELPLESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PARTTIME EMPLOYMENT; PRODUCTIVITY; PRURITUS; PSORIASIS; PSORIATIC ARTHRITIS; QUALITY OF LIFE; SELF CONCEPT; SKIN IRRITATION; TELEPHONE; UNEMPLOYMENT; UNITED STATES; WELLBEING;

ABSENTEEISM; ADULT; AGED; DATA COLLECTION; EFFICIENCY; FEMALE; FOUNDATIONS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; TIME FACTORS; UNITED STATES; WORK; WORKPLACE;

EID: 84871684960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052935     Document Type: Article

References (17)

1. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T, (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. The journal of investigative dermatology Symposium proceedings/the Society for Investigative Dermatology, Inc [and] European Society for Dermatological Research 9: 136-139.
2. Gupta MA, Gupta AK, Watteel GN, (1998) Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis 61: 339-342.
3. Schmid-Ott G, Jaeger B, Kuensebeck HW, Ott R, Lamprecht F, (1996) Dimensions of stigmatization in patients with psoriasis in a "Questionnaire on Experience with Skin Complaints". Dermatology 193: 304-310.
4. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, et al. (2007) Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 57: 963-971.
5. Pearce DJ, Singh S, Balkrishnan R, Kulkarni A, Fleischer AB, et al. (2006) The negative impact of psoriasis on the workplace. J Dermatolog Treat 17: 24-28.
6. Feldman SR, Koo JY, Menter A, Bagel J, (2005) Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol 53: 101-107.
7. Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, et al. (2007) National Psoriasis Foundation clinical consensus on disease severity. Archives of dermatology 143: 239-242.
8. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, et al. (2007) Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. Journal of the American Academy of Dermatology 57: 957-962.
9. Saad AA, Ashcroft DM, Watson KD, Symmons DP, Noyce PR, et al. (2010) Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies. Arthritis Care Res (Hoboken) 62: 345-353.
10. Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, et al. (2009) Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial. J Eur Acad Dermatol Venereol 23: 919-926.
11. Kimball AB, Yu AP, Signorovitch J, Xie J, Tsaneva M, et al. (2012) The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol 66: e67-76.
12. Revicki DA, Menter A, Feldman S, Kimel M, Harnam N, et al. (2008) Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Health Qual Life Outcomes 6: 75.
13. Reich K, Griffiths CE, (2008) The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab. Arch Dermatol Res 300: 537-544.
14. (2012) National Psoriasis Foundation.
15. Spandonaro F, Altomare G, Berardesca E, Calzavara-Pinton P, Chimenti S, et al. (2011) Health-related quality of life in psoriasis: an analysis of Psocare project patients. G Ital Dermatol Venereol 146: 169-177.
16. Palota T, Szepietowski JC, Pec J, Arenberger P, Giurcaneanu C, et al. (2010) A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. Acta Dermatovenerol Croat 18: 151-161.
17. Bronsard V, Paul C, Prey S, Puzenat E, Gourraud PA, et al. (2010) What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 24Suppl 2: 17-22.